| 发明名称 |
Crystalline forms of (<i>R</i>)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1<i>H</i>-3-benzazepine hydrochloride |
| 摘要 |
The present invention is directed to crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, compositions containing the same and uses thereof. |
| 申请公布号 |
US8980881(B2) |
申请公布日期 |
2015.03.17 |
| 申请号 |
US201213616887 |
申请日期 |
2012.09.14 |
| 申请人 |
Arena Pharmaceuticals, Inc. |
发明人 |
Agarwal Rajesh K.;Betts, III William L.;Henshilwood James A.;Kiang Yuan-Hon;Post Noah |
| 分类号 |
A61K31/55;C07D223/16;A61P3/04 |
主分类号 |
A61K31/55 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treatment of obesity comprising administering to an individual in need of such treatment a therapeutically effective amount of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride hemihydrate. |
| 地址 |
San Diego CA US |
